518 related articles for article (PubMed ID: 9496338)
21. Depo Provera: still controversial.
Wren LM
Int Health News; 1988 Feb; 9(2):2-3, 8. PubMed ID: 12179873
[TBL] [Abstract][Full Text] [Related]
22. Establishing the minimum effective dose and additive effects of depot progestin in suppression of human spermatogenesis by a testosterone depot.
Handelsman DJ; Conway AJ; Howe CJ; Turner L; Mackey MA
J Clin Endocrinol Metab; 1996 Nov; 81(11):4113-21. PubMed ID: 8923869
[TBL] [Abstract][Full Text] [Related]
23. Depo-Provera: just another contraceptive?
Jones M
Fertil Contracept; 1978 Apr; 2(2):26-9. PubMed ID: 12336094
[TBL] [Abstract][Full Text] [Related]
24. Concentration of fat, protein, lactose and energy in milk of mothers using hormonal contraceptives.
Costa TH; Dorea JG
Ann Trop Paediatr; 1992; 12(2):203-9. PubMed ID: 1381897
[TBL] [Abstract][Full Text] [Related]
25. Adolescent satisfaction with postpartum contraception and body weight concerns.
Hellerstedt WL; Story M
J Adolesc Health; 1998 Jun; 22(6):446-52. PubMed ID: 9627814
[TBL] [Abstract][Full Text] [Related]
26. Depo Provera. Position paper on clinical use, effectiveness and side effects.
Bigrigg A; Evans M; Gbolade B; Newton J; Pollard L; Szarewski A; Thomas C; Walling M
Br J Fam Plann; 1999 Jul; 25(2):69-76. PubMed ID: 10454658
[TBL] [Abstract][Full Text] [Related]
27. Clinical trial to evaluate pharmacokinetics and pharmacodynamics of medroxyprogesterone acetate after subcutaneous administration of Depo-Provera.
Halpern V; Brache V; Taylor D; Lendvay A; Cochón L; Jensen JT; Dorflinger LJ
Fertil Steril; 2021 Apr; 115(4):1035-1043. PubMed ID: 33485608
[TBL] [Abstract][Full Text] [Related]
28. Bone density in long term users of depot medroxyprogesterone acetate.
Gbolade B; Ellis S; Murby B; Randall S; Kirkman R
Br J Obstet Gynaecol; 1998 Jul; 105(7):790-4. PubMed ID: 9692421
[TBL] [Abstract][Full Text] [Related]
29. Lunelle monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension): effects of body weight and injection sites on pharmacokinetics.
Rahimy MH; Cromie MA; Hopkins NK; Tong DM
Contraception; 1999 Oct; 60(4):201-8. PubMed ID: 10640166
[TBL] [Abstract][Full Text] [Related]
30. A case for concern?
Gartland A
Nurs Times; 1983 May 4-10; 79(18):10-1. PubMed ID: 6222288
[TBL] [Abstract][Full Text] [Related]
31. Long-acting steroids provide new options.
Netw Res Triangle Park N C; 1988; 9(3):1-3, 7. PubMed ID: 12315656
[TBL] [Abstract][Full Text] [Related]
32. Long-term depot-medroxyprogesterone acetate and bone mineral density.
Tang OS; Tang G; Yip P; Li B; Fan S
Contraception; 1999 Jan; 59(1):25-9. PubMed ID: 10342083
[TBL] [Abstract][Full Text] [Related]
33. Return of fertility after discontinuation of depot medroxyprogesterone acetate and intra-uterine devices in Northern Thailand.
Pardthaisong T; Gray RH; McDaniel EB
Lancet; 1980 Mar; 1(8167):509-12. PubMed ID: 6102234
[TBL] [Abstract][Full Text] [Related]
34. Serum immunoglobulin levels during contraceptive use of depot-medroxyprogesterone acetate in Indian women: a preliminary study.
Lali P; Chandra L; Gupta RP
Contraception; 1996 Jun; 53(6):363-5. PubMed ID: 8773424
[TBL] [Abstract][Full Text] [Related]
35. Extracts from the report on the Joint IGCC/IFRP East and South East Asia Seminar on Regional Fertility Research.
Mcdaniel EB
IGCC News; 1980 Jan; 5(3):1-4. PubMed ID: 12179403
[TBL] [Abstract][Full Text] [Related]
36. The use of depot medroxyprogesterone acetate (DMPA) injectable contraceptive in Enugu, Nigeria.
Hu E; Ikeako LC; Obiora-Okafor NC
Niger J Med; 2012; 21(3):266-71. PubMed ID: 23304918
[TBL] [Abstract][Full Text] [Related]
37. Depo-Provera: a critical analysis.
Minkin S
Women Health; 1980; 5(2):49-69. PubMed ID: 6451987
[TBL] [Abstract][Full Text] [Related]
38. Endometrial histology and circulating levels of medroxyprogesterone acetate (MPA), estradiol, FSH and LH in women with MPA induced amenorrhoea compared with women with secondary amenorrhoea.
Jeppsson S; Johansson ED; Ljungberg O; Sjöberg NO
Acta Obstet Gynecol Scand; 1977; 56(1):43-8. PubMed ID: 842303
[TBL] [Abstract][Full Text] [Related]
39. Effect of Depo-Provera or Microgynon on the painful crises of sickle cell anemia patients.
de Abood M; de Castillo Z; Guerrero F; Espino M; Austin KL
Contraception; 1997 Nov; 56(5):313-6. PubMed ID: 9437560
[TBL] [Abstract][Full Text] [Related]
40. A phase I comparative study of three contraceptive vaginal films containing nonoxynol-9. Postcoital testing and colposcopy.
Mauck CK; Baker JM; Barr SP; Johanson WM; Archer DF
Contraception; 1997 Aug; 56(2):97-102. PubMed ID: 9315418
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
